查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1715668

醫藥契約製造和研究服務市場（按服務類型和最終用戶）—2025-2030 年全球預測

Pharmaceutical Contract Manufacturing & Research Services Market by Service Type, End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 182 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2024 年，醫藥契約製造和研究服務市場價值估計為 1,950.9 億美元，預計到 2025 年將成長至 2,148.7 億美元，複合年成長率為 10.55%，預計到 2030 年將達到 3,562.7 億美元。

主要市場統計數據
基準年2024年 1950.9億美元
預計2025年 2148.7億美元
預測年份 2030 3562.7億美元
複合年成長率（%） 10.55%

醫藥契約製造和研究服務已成為現代醫療保健生態系統的核心支柱。在過去十年中，在技術進步、法規環境不斷擴大和全球健康需求不斷成長的推動下，該行業經歷了重大轉型。從專業顧問公司到綜合製造和研究機構，市場參與者現在比以往任何時候都更加敏捷和創新。

在控制成本、確保品質和縮短藥物開發時間的壓力下，最近的趨勢迫使公司重新調整策略以保持競爭力。這種動態情勢迫使企業簡化業務、創新流程並實現數位化整合。

這種轉變不僅僅是業務的；它也正在重塑許多公司的策略格局。公司正在尋求整合諮詢、製造和研究主導的洞察力的端到端解決方案，以便為其客戶和相關人員提供更強大的成果。這種綜合方法最佳化了產品生命週期的每個階段，從早期發現到臨床開發、最終配方和上市。

對速度和效率日益成長的需求迫使製藥業相關人員投資於先進的製造技術和研究能力。創新科學、嚴格的法規和全球市場壓力的結合正在重新定義製藥業對品質和性能的期望和基準。

醫藥契約製造與研究服務市場的轉型

該行業正在經歷由內部發展和外部市場力量共同推動的模式轉移。數位轉型、自動化和人工智慧在重組生產流程、減少錯誤率和加快調查流程方面發揮著重要作用。隨著組織採用尖端流程最佳化工具，改進的數據分析正在實現預測洞察和即時決策。

安全、品質和環境合規性不斷變化的需求迫使公司重新思考其整個業務方式。作為回應，許多公司正在對其供應鏈和生產生態系統進行重大改革，以滿足這些新標準。這種轉變正在加速產業整合，小型利基企業和全球巨頭之間正在建立夥伴關係。我們今天看到的協作模式強調通用致力於提高效率並確保所有流程符合嚴格的監管要求。

越來越多的公司正在整合外包功能以填補利基能力的空白，而現有企業則透過投資客製化技術來擴大其投資組合，以提高產出的品質和一致性。生物技術和製程工程的快速進步使該行業走到了十字路口。我們正在重新評估傳統模式，以獲得更全面、以患者為中心和技術主導的策略。這種轉變從根本上改變了我們處理每項業務的方式，從最初的想法和研究到最終產品的發現和發展。

跨服務和最終用戶的關鍵細分洞察

細緻地了解服務類型細分對於理解市場的多面性至關重要。服務業全面分為諮詢服務、製造服務和研究服務，每種服務都有自己的動態。在諮詢服務領域，除了監管諮詢外，研究也著重於品質保證諮詢，強調強而有力的合規制度的重要性。在製造領域，不僅可以從原料藥和生技藥品製造中獲得見解，還可以從成品藥品製造的複雜細節中獲得見解，分為液體、半固態和固態劑型。這種詳細的細分使相關人員能夠準確地找出因製造流程和配方類型而異的特定挑戰和機會。

研究服務也受到關注。這些服務涵蓋生物分析評估、綜合臨床研究操作、先進藥物發現和臨床前研究以及毒理學研究等專業領域。透過評估 I 期、II 期和 III 期臨床試驗，臨床研究服務可實現進一步的細化。這種詳細的細分有助於根據研究舉措的成熟度和重點來確定有針對性的投資機會和策略重點。

同時，市場研究根據最終用戶分析擴大了細分範圍，涵蓋了學術和政府研究機構、生物技術公司和大型製藥公司等主要群體。每個客戶群都有不同的需求和決策模式，直接影響他們的服務採用模式。這種多層次的細分框架確保 Market Insights 能夠捕捉服務需求和最終用戶期望的多樣性，從而提供不斷變化的行業格局的全面視圖。

目錄

第1章 引言

第2章調查方法

第3章執行摘要

第4章 市場概述

第5章 市場洞察

  • 市場動態
    • 驅動程式
      • 慢性病的增加和人口老化正在推動對契約製造服務的依賴性增加
      • 全球醫療成本和藥品產量不斷上升
      • 對生技藥品和個人化醫療的日益關注推動了藥物研究的成長
    • 限制因素
      • 外包供應商和製藥公司之間的品質差異所帶來的風險
    • 機會
      • 先進技術與自動化在藥品生產與研究的融合
      • 製藥公司不斷增加對研發的投資，需要合約服務的額外支援。
    • 任務
      • 各國監理標準各有不同
  • 市場區隔分析
    • 服務類型：製造服務受偏好
    • 最終用戶：學術機構和政府研究機構擴大採用先進技術和專業知識
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社會
    • 技術的
    • 合法的
    • 環境

第6章醫藥契約製造與研究服務市場（依服務類型）

  • 諮詢服務
    • 品質保證諮詢
    • 監理諮詢
  • 製造服務
    • API 製造
    • 生物製藥製造
    • 成品劑型的生產
      • 液體製劑
      • 半固體製劑
      • 固態製劑
  • 研究服務
    • 生物分析服務
    • 臨床研究服務
      • I期臨床試驗
      • II期臨床試驗
      • III期臨床試驗
    • 藥物研發
    • 臨床前研究
    • 毒理學研究

第7章 醫藥契約製造和研究服務市場（按最終用戶）

  • 學術和政府研究組織
  • 生技公司
  • 製藥公司

8.美洲藥品契約製造與研究服務市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

9. 亞太醫藥契約製造與研究服務市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第10章歐洲、中東和非洲醫藥契約製造和研究服務市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第11章競爭格局

  • 2024年市場佔有率分析
  • 2024年FPNV定位矩陣
  • 競爭情境分析
  • 戰略分析與建議

公司名單

  • AbbVie Inc
  • Almac Group
  • Amanta Healthcare Ltd.
  • Aragen Life Sciences Ltd.
  • Automatic Liquid Packaging Solutions LLC
  • Baxter Pharmaceutical Solutions LLC
  • Boehringer Ingelheim International GmbH
  • Cambrex Corporation
  • Catalent, Inc
  • Curida AS
  • Dalton Pharma Services
  • Evonik Industries AG
  • Famar Group
  • Horizon Pharmaceuticals, Inc
  • Laboratorios SALVAT, SA
  • Lonza Group Ltd.
  • Nephron Pharmaceuticals Corporation
  • Pfizer, Inc.
  • Recipharm AB
  • Rommelag SE & Co. KG
  • Rusoma Laboratories Private Limited
  • Silgan Unicep
  • Unither Pharmaceuticals SAS
  • UPM Pharmaceuticals, Inc.
  • Woodstock Sterile Solutions
Product Code: MRR-AD36CD898497

The Pharmaceutical Contract Manufacturing & Research Services Market was valued at USD 195.09 billion in 2024 and is projected to grow to USD 214.87 billion in 2025, with a CAGR of 10.55%, reaching USD 356.27 billion by 2030.

KEY MARKET STATISTICS
Base Year [2024] USD 195.09 billion
Estimated Year [2025] USD 214.87 billion
Forecast Year [2030] USD 356.27 billion
CAGR (%) 10.55%

Pharmaceutical contract manufacturing and research services have emerged as central pillars in the modern healthcare ecosystem. Over the past decade, this sector has experienced significant transformation fueled by technological advancements, an expanding regulatory environment, and rising global health demands. Market players, ranging from specialized consultancies to full-service manufacturing and research organizations, are now more agile and innovative than ever.

In recent years, companies have had to recalibrate their strategies in order to maintain competitiveness amidst pressures such as cost control, quality assurance, and accelerated drug development timelines. This dynamic landscape has prompted organizations to streamline operations, innovate processes, and embrace digital integration, all while adhering to ever-tightening regulatory frameworks.

The transformation is not just operational but is also reshaping the strategic outlook of many enterprises. Firms are pursuing end-to-end solutions that integrate consulting, manufacturing, and research-driven insights to deliver more robust outcomes for their clients and stakeholders. This integrated approach ensures that every stage of the product lifecycle is optimized-from early drug discovery and clinical development to final dosage formulation and market delivery.

With increasing demand for speed and efficiency, stakeholders across the pharmaceutical spectrum are compelled to invest in advanced manufacturing technologies and research capabilities. The confluence of innovative science, strict regulatory mandates, and global market pressures has redefined the expectations and benchmarks for quality and performance within the industry.

Transformative Shifts in the Pharmaceutical Manufacturing & Research Landscape

The industry is witnessing a paradigm shift driven by both internal evolution and external market forces. Digital transformation, automation, and artificial intelligence are playing essential roles in reengineering production workflows, reducing error margins, and expediting research processes. As organizations adopt state-of-the-art process optimization tools, improved data analytics are enabling predictive insights and real-time decision-making.

Regulatory bodies are also raising the bar; the evolving requirements for safety, quality, and environmental compliance are urging companies to reimagine their entire operational methodologies. In response, many organizations are undertaking major overhauls of their supply chain and production ecosystems in order to meet these new standards. This transition has accelerated industry consolidation, with partnerships emerging between smaller niche players and global giants. The collaboration models seen today highlight a shared commitment to enhancing efficiency and ensuring all processes comply with stringent regulatory requirements.

An increasing number of firms are integrating outsourced functionalities to fill gaps in niche capabilities, while established companies are expanding their portfolios by investing in bespoke technologies for higher quality and output consistency. Rapid advancements in biotechnology and process engineering have positioned the industry at a crossroads where traditional models are being revisited in favor of more holistic, patient-centric, and technology-driven strategies. This change is fundamentally altering how businesses approach everything from initial ideation and research to the discovery and formulation of finished products.

Key Segmentation Insights Across Services and End-Users

A nuanced understanding of service type segmentation is vital to appreciate the multifaceted nature of the market. The service landscape is comprehensively divided into consulting services, manufacturing services, and research services, each with its own unique dynamics. Under consulting services, there is a focused study on quality assurance consulting alongside regulatory consulting, emphasizing the critical need for robust compliance frameworks. In the manufacturing domain, insights are drawn not only from API manufacturing and biologics manufacturing, but also from the intricate details of finished dosage form manufacturing, further subdivided into liquid formulations, semi-solid formulations, and solid formulations. This in-depth segmentation allows stakeholders to pinpoint the specific challenges and opportunities that vary depending on the manufacturing process or formulation type.

Research services have been given equal measure of attention. These services cover bioanalytical assessments, comprehensive clinical research undertakings, the progressive fields of drug discovery and preclinical research, as well as the specialized area of toxicology studies. Within clinical research services, further granularity is achieved by evaluating phase I, phase II, and phase III clinical trials. Such detailed segmentation helps to elucidate targeted investment opportunities and strategic priorities based on the maturity and focus of research initiatives.

In parallel, the market study extends its segmentation based on end-user analysis, examining key groups such as academic and government research institutes, biotechnology companies, and large pharmaceutical companies. Each customer group has distinct needs and decision-making paradigms that directly influence service adoption patterns. This multi-layered segmentation framework ensures that market insights capture the diversity of service demands and end-user expectations, providing a comprehensive view of the industry's evolving landscape.

Based on Service Type, market is studied across Consulting Services, Manufacturing Services, and Research Services. The Consulting Services is further studied across Quality Assurance Consulting and Regulatory Consulting. The Manufacturing Services is further studied across API Manufacturing, Biologics Manufacturing, and Finished Dosage Form Manufacturing. The Finished Dosage Form Manufacturing is further studied across Liquid Formulations, Semi-Aolid Formulations, and Solid Formulations. The Research Services is further studied across Bioanalytical Services, Clinical Research Services, Drug Discovery, Preclinical Research, and Toxicology Studies. The Clinical Research Services is further studied across Phase I Clinical Trials, Phase II Clinical Trials, and Phase III Clinical Trials.

Based on End-User, market is studied across Academic & Government Research Institutes, Biotechnology Companies, and Pharmaceutical Companies.

Key Regional Insights Shaping Global Market Dynamics

Regional market dynamics play a crucial role in shaping the direction and pace of expansion in pharmaceutical contract manufacturing and research services. The Americas continue to be a crucial driver of growth, with North America embracing extensive investments in advanced research facilities and state-of-the-art manufacturing infrastructures. Meanwhile, the Europe, Middle East & Africa region showcases a rich blend of mature markets and emerging economies. This dynamic mix contributes to steady demand for high-quality services, driven by stringent regulatory requirements and a commitment to innovation in healthcare.

In the Asia-Pacific region, rapid industrialization coupled with increased investment in healthcare is opening up significant new opportunities. Emerging economies in this region are not only becoming key players in manufacturing but are also showing substantial progress in clinical research, driven by favorable government policies and a robust talent pool. Regional collaborations, strategic local partnerships, and a focus on cost-effective manufacturing are helping to cement the significance of Asia-Pacific in the global market. Collectively, these regional insights underscore the need for tailored strategies that address unique local market conditions while leveraging global best practices to drive sustainable growth.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

Key Companies Driving Innovation and Market Leadership

The competitive landscape in the pharmaceutical contract manufacturing and research arena is defined by an assembly of top-tier companies that have redefined industry benchmarks. Notable players such as AbbVie Inc and Almac Group set high standards through their persistent commitment to quality and innovation. Organizations like Amanta Healthcare Ltd. and Aragen Life Sciences Ltd. distinguish themselves through specialized service offerings and agile operational capabilities that cater to emerging market needs.

Additional leaders including Automatic Liquid Packaging Solutions LLC, Baxter Pharmaceutical Solutions LLC, and Boehringer Ingelheim International GmbH exemplify operational excellence and strategic foresight. Their robust portfolios, combined with investments in cutting-edge technologies, have enabled them to secure strong positions within the manufacturing sector. Companies such as Cambrex Corporation and Catalent, Inc further elevate industry standards by integrating advanced research capabilities with streamlined manufacturing processes. Curida AS and Dalton Pharma Services similarly enhance service excellence through their innovative approaches to regulatory adherence and quality management systems.

Other influential entities such as Evonik Industries AG, Famar Group, and Horizon Pharmaceuticals, Inc have expanded their global footprint by leveraging strategic partnerships and state-of-the-art production methodologies. Firms like Laboratorios SALVAT, S.A, Lonza Group Ltd., and Nephron Pharmaceuticals Corporation further illustrate the value of deep market expertise and operational agility. Industry benchmarks are continuously challenged by key players including Pfizer, Inc., Recipharm AB, and Rommelag SE & Co. KG. Emerging companies such as Rusoma Laboratories Private Limited, Silgan Unicep, Unither Pharmaceuticals SAS, UPM Pharmaceuticals, Inc., and Woodstock Sterile Solutions are also gaining prominence by combining local insights with international best practices, thus adding vibrancy and competitive depth to the market.

The report delves into recent significant developments in the Pharmaceutical Contract Manufacturing & Research Services Market, highlighting leading vendors and their innovative profiles. These include AbbVie Inc, Almac Group, Amanta Healthcare Ltd., Aragen Life Sciences Ltd., Automatic Liquid Packaging Solutions LLC, Baxter Pharmaceutical Solutions LLC, Boehringer Ingelheim International GmbH, Cambrex Corporation, Catalent, Inc, Curida AS, Dalton Pharma Services, Evonik Industries AG, Famar Group, Horizon Pharmaceuticals, Inc, Laboratorios SALVAT, S.A, Lonza Group Ltd., Nephron Pharmaceuticals Corporation, Pfizer, Inc., Recipharm AB, Rommelag SE & Co. KG, Rusoma Laboratories Private Limited, Silgan Unicep, Unither Pharmaceuticals SAS, UPM Pharmaceuticals, Inc., and Woodstock Sterile Solutions. Actionable Recommendations for Steering Market Growth

Leaders in the industry are advised to pursue innovation and develop integrated service portfolios that bridge consulting, manufacturing, and research. It is crucial to invest in automation, digitalization, and advanced analytics to drive consistent improvements in production efficiency and regulatory compliance. Companies should also expand their geographic footprints by establishing strategic alliances and leveraging local market expertise.

A key recommendation is to prioritize investments in research and development while seeking collaborative opportunities that blend academic excellence with industry experience. Engaging in strategic partnerships can not only bolster service capabilities but also mitigate operational risks. Furthermore, ensuring rigorous quality control and agile response systems to regulatory changes will be essential to maintaining competitive advantage in an increasingly complex environment. Emphasis on digital transformation is paramount, as the incorporation of data-driven strategies will refine decision-making processes and support sustained growth.

Conclusion Summarizing Strategic Insights and Market Evolution

The current landscape of pharmaceutical contract manufacturing and research services is marked by rapid innovation, strategic shifts, and evolving market segmentation. Technological advancements, changing regulatory requirements, and global market expansion continue to shape the industry's trajectory. By understanding the intricacies of service type and end-user segmentation, alongside recognizing key regional and corporate dynamics, stakeholders are better positioned to capitalize on emerging opportunities. Overall, strategic integration and agile operations remain the cornerstones of sustained market leadership.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing prevalence of chronic diseases and the aging population increasing reliance on contract manufacturing services
      • 5.1.1.2. Rising healthcare expenditure and pharmaceutical production worldwide
      • 5.1.1.3. Increasing emphasis on biologics and personalized medicine fuels growth in pharmaceutical research
    • 5.1.2. Restraints
      • 5.1.2.1. Risk associated with quality discrepancies between the outsourcing vendor and the pharmaceutical company
    • 5.1.3. Opportunities
      • 5.1.3.1. Integration of advanced technologies and automation in pharmaceutical manufacturing and research
      • 5.1.3.2. Increasing investments in research and development by pharmaceutical companies require additional support from contract services
    • 5.1.4. Challenges
      • 5.1.4.1. Varying regulatory standards across different countries
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Service Type: Increasing preference for manufacturing services
    • 5.2.2. End-User: Rising adoption in academic & government research institutes to access advanced technology and expertise
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Pharmaceutical Contract Manufacturing & Research Services Market, by Service Type

  • 6.1. Introduction
  • 6.2. Consulting Services
    • 6.2.1. Quality Assurance Consulting
    • 6.2.2. Regulatory Consulting
  • 6.3. Manufacturing Services
    • 6.3.1. API Manufacturing
    • 6.3.2. Biologics Manufacturing
    • 6.3.3. Finished Dosage Form Manufacturing
      • 6.3.3.1. Liquid Formulations
      • 6.3.3.2. Semi-Aolid Formulations
      • 6.3.3.3. Solid Formulations
  • 6.4. Research Services
    • 6.4.1. Bioanalytical Services
    • 6.4.2. Clinical Research Services
      • 6.4.2.1. Phase I Clinical Trials
      • 6.4.2.2. Phase II Clinical Trials
      • 6.4.2.3. Phase III Clinical Trials
    • 6.4.3. Drug Discovery
    • 6.4.4. Preclinical Research
    • 6.4.5. Toxicology Studies

7. Pharmaceutical Contract Manufacturing & Research Services Market, by End-User

  • 7.1. Introduction
  • 7.2. Academic & Government Research Institutes
  • 7.3. Biotechnology Companies
  • 7.4. Pharmaceutical Companies

8. Americas Pharmaceutical Contract Manufacturing & Research Services Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Pharmaceutical Contract Manufacturing & Research Services Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Pharmaceutical Contract Manufacturing & Research Services Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2024
  • 11.2. FPNV Positioning Matrix, 2024
  • 11.3. Competitive Scenario Analysis
    • 11.3.1. Oncimmune Holdings secures breakthrough USD 1.5 million contract
    • 11.3.2. Charles River and Gates Institute's strategic partnership advances CAR-T therapy production
    • 11.3.3. FAMAR and Lavipharm collaboration strengthens Greek pharmaceutical production
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. AbbVie Inc
  • 2. Almac Group
  • 3. Amanta Healthcare Ltd.
  • 4. Aragen Life Sciences Ltd.
  • 5. Automatic Liquid Packaging Solutions LLC
  • 6. Baxter Pharmaceutical Solutions LLC
  • 7. Boehringer Ingelheim International GmbH
  • 8. Cambrex Corporation
  • 9. Catalent, Inc
  • 10. Curida AS
  • 11. Dalton Pharma Services
  • 12. Evonik Industries AG
  • 13. Famar Group
  • 14. Horizon Pharmaceuticals, Inc
  • 15. Laboratorios SALVAT, S.A
  • 16. Lonza Group Ltd.
  • 17. Nephron Pharmaceuticals Corporation
  • 18. Pfizer, Inc.
  • 19. Recipharm AB
  • 20. Rommelag SE & Co. KG
  • 21. Rusoma Laboratories Private Limited
  • 22. Silgan Unicep
  • 23. Unither Pharmaceuticals SAS
  • 24. UPM Pharmaceuticals, Inc.
  • 25. Woodstock Sterile Solutions

LIST OF FIGURES

  • FIGURE 1. PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET MULTI-CURRENCY
  • FIGURE 2. PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET MULTI-LANGUAGE
  • FIGURE 3. PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET RESEARCH PROCESS
  • FIGURE 4. PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, 2024 VS 2030
  • FIGURE 5. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 6. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 7. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY SERVICE TYPE, 2024 VS 2030 (%)
  • FIGURE 9. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY SERVICE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY END-USER, 2024 VS 2030 (%)
  • FIGURE 11. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY END-USER, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 13. AMERICAS PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY STATE, 2024 VS 2030 (%)
  • FIGURE 15. UNITED STATES PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 20. PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 21. PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET DYNAMICS
  • TABLE 7. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY CONSULTING SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY QUALITY ASSURANCE CONSULTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY REGULATORY CONSULTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY CONSULTING SERVICES, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY MANUFACTURING SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY API MANUFACTURING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY BIOLOGICS MANUFACTURING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY FINISHED DOSAGE FORM MANUFACTURING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY LIQUID FORMULATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY SEMI-AOLID FORMULATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY SOLID FORMULATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY FINISHED DOSAGE FORM MANUFACTURING, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY MANUFACTURING SERVICES, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY RESEARCH SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY BIOANALYTICAL SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY CLINICAL RESEARCH SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY PHASE I CLINICAL TRIALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY PHASE II CLINICAL TRIALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY PHASE III CLINICAL TRIALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY CLINICAL RESEARCH SERVICES, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY PRECLINICAL RESEARCH, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY TOXICOLOGY STUDIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY RESEARCH SERVICES, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY ACADEMIC & GOVERNMENT RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 34. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 35. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 36. AMERICAS PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 37. AMERICAS PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY CONSULTING SERVICES, 2018-2030 (USD MILLION)
  • TABLE 38. AMERICAS PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY MANUFACTURING SERVICES, 2018-2030 (USD MILLION)
  • TABLE 39. AMERICAS PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY FINISHED DOSAGE FORM MANUFACTURING, 2018-2030 (USD MILLION)
  • TABLE 40. AMERICAS PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY RESEARCH SERVICES, 2018-2030 (USD MILLION)
  • TABLE 41. AMERICAS PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY CLINICAL RESEARCH SERVICES, 2018-2030 (USD MILLION)
  • TABLE 42. AMERICAS PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 43. AMERICAS PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 44. ARGENTINA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 45. ARGENTINA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY CONSULTING SERVICES, 2018-2030 (USD MILLION)
  • TABLE 46. ARGENTINA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY MANUFACTURING SERVICES, 2018-2030 (USD MILLION)
  • TABLE 47. ARGENTINA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY FINISHED DOSAGE FORM MANUFACTURING, 2018-2030 (USD MILLION)
  • TABLE 48. ARGENTINA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY RESEARCH SERVICES, 2018-2030 (USD MILLION)
  • TABLE 49. ARGENTINA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY CLINICAL RESEARCH SERVICES, 2018-2030 (USD MILLION)
  • TABLE 50. ARGENTINA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 51. BRAZIL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 52. BRAZIL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY CONSULTING SERVICES, 2018-2030 (USD MILLION)
  • TABLE 53. BRAZIL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY MANUFACTURING SERVICES, 2018-2030 (USD MILLION)
  • TABLE 54. BRAZIL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY FINISHED DOSAGE FORM MANUFACTURING, 2018-2030 (USD MILLION)
  • TABLE 55. BRAZIL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY RESEARCH SERVICES, 2018-2030 (USD MILLION)
  • TABLE 56. BRAZIL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY CLINICAL RESEARCH SERVICES, 2018-2030 (USD MILLION)
  • TABLE 57. BRAZIL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 58. CANADA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 59. CANADA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY CONSULTING SERVICES, 2018-2030 (USD MILLION)
  • TABLE 60. CANADA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY MANUFACTURING SERVICES, 2018-2030 (USD MILLION)
  • TABLE 61. CANADA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY FINISHED DOSAGE FORM MANUFACTURING, 2018-2030 (USD MILLION)
  • TABLE 62. CANADA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY RESEARCH SERVICES, 2018-2030 (USD MILLION)
  • TABLE 63. CANADA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY CLINICAL RESEARCH SERVICES, 2018-2030 (USD MILLION)
  • TABLE 64. CANADA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 65. MEXICO PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 66. MEXICO PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY CONSULTING SERVICES, 2018-2030 (USD MILLION)
  • TABLE 67. MEXICO PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY MANUFACTURING SERVICES, 2018-2030 (USD MILLION)
  • TABLE 68. MEXICO PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY FINISHED DOSAGE FORM MANUFACTURING, 2018-2030 (USD MILLION)
  • TABLE 69. MEXICO PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY RESEARCH SERVICES, 2018-2030 (USD MILLION)
  • TABLE 70. MEXICO PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY CLINICAL RESEARCH SERVICES, 2018-2030 (USD MILLION)
  • TABLE 71. MEXICO PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 72. UNITED STATES PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. UNITED STATES PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY CONSULTING SERVICES, 2018-2030 (USD MILLION)
  • TABLE 74. UNITED STATES PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY MANUFACTURING SERVICES, 2018-2030 (USD MILLION)
  • TABLE 75. UNITED STATES PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY FINISHED DOSAGE FORM MANUFACTURING, 2018-2030 (USD MILLION)
  • TABLE 76. UNITED STATES PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY RESEARCH SERVICES, 2018-2030 (USD MILLION)
  • TABLE 77. UNITED STATES PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY CLINICAL RESEARCH SERVICES, 2018-2030 (USD MILLION)
  • TABLE 78. UNITED STATES PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 79. UNITED STATES PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 80. ASIA-PACIFIC PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 81. ASIA-PACIFIC PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY CONSULTING SERVICES, 2018-2030 (USD MILLION)
  • TABLE 82. ASIA-PACIFIC PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY MANUFACTURING SERVICES, 2018-2030 (USD MILLION)
  • TABLE 83. ASIA-PACIFIC PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY FINISHED DOSAGE FORM MANUFACTURING, 2018-2030 (USD MILLION)
  • TABLE 84. ASIA-PACIFIC PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY RESEARCH SERVICES, 2018-2030 (USD MILLION)
  • TABLE 85. ASIA-PACIFIC PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY CLINICAL RESEARCH SERVICES, 2018-2030 (USD MILLION)
  • TABLE 86. ASIA-PACIFIC PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 87. ASIA-PACIFIC PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 88. AUSTRALIA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. AUSTRALIA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY CONSULTING SERVICES, 2018-2030 (USD MILLION)
  • TABLE 90. AUSTRALIA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY MANUFACTURING SERVICES, 2018-2030 (USD MILLION)
  • TABLE 91. AUSTRALIA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY FINISHED DOSAGE FORM MANUFACTURING, 2018-2030 (USD MILLION)
  • TABLE 92. AUSTRALIA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY RESEARCH SERVICES, 2018-2030 (USD MILLION)
  • TABLE 93. AUSTRALIA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY CLINICAL RESEARCH SERVICES, 2018-2030 (USD MILLION)
  • TABLE 94. AUSTRALIA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 95. CHINA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 96. CHINA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY CONSULTING SERVICES, 2018-2030 (USD MILLION)
  • TABLE 97. CHINA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY MANUFACTURING SERVICES, 2018-2030 (USD MILLION)
  • TABLE 98. CHINA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY FINISHED DOSAGE FORM MANUFACTURING, 2018-2030 (USD MILLION)
  • TABLE 99. CHINA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY RESEARCH SERVICES, 2018-2030 (USD MILLION)
  • TABLE 100. CHINA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY CLINICAL RESEARCH SERVICES, 2018-2030 (USD MILLION)
  • TABLE 101. CHINA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 102. INDIA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 103. INDIA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY CONSULTING SERVICES, 2018-2030 (USD MILLION)
  • TABLE 104. INDIA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY MANUFACTURING SERVICES, 2018-2030 (USD MILLION)
  • TABLE 105. INDIA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY FINISHED DOSAGE FORM MANUFACTURING, 2018-2030 (USD MILLION)
  • TABLE 106. INDIA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY RESEARCH SERVICES, 2018-2030 (USD MILLION)
  • TABLE 107. INDIA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY CLINICAL RESEARCH SERVICES, 2018-2030 (USD MILLION)
  • TABLE 108. INDIA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 109. INDONESIA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 110. INDONESIA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY CONSULTING SERVICES, 2018-2030 (USD MILLION)
  • TABLE 111. INDONESIA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY MANUFACTURING SERVICES, 2018-2030 (USD MILLION)
  • TABLE 112. INDONESIA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY FINISHED DOSAGE FORM MANUFACTURING, 2018-2030 (USD MILLION)
  • TABLE 113. INDONESIA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY RESEARCH SERVICES, 2018-2030 (USD MILLION)
  • TABLE 114. INDONESIA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY CLINICAL RESEARCH SERVICES, 2018-2030 (USD MILLION)
  • TABLE 115. INDONESIA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 116. JAPAN PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 117. JAPAN PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY CONSULTING SERVICES, 2018-2030 (USD MILLION)
  • TABLE 118. JAPAN PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY MANUFACTURING SERVICES, 2018-2030 (USD MILLION)
  • TABLE 119. JAPAN PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY FINISHED DOSAGE FORM MANUFACTURING, 2018-2030 (USD MILLION)
  • TABLE 120. JAPAN PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY RESEARCH SERVICES, 2018-2030 (USD MILLION)
  • TABLE 121. JAPAN PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY CLINICAL RESEARCH SERVICES, 2018-2030 (USD MILLION)
  • TABLE 122. JAPAN PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 123. MALAYSIA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 124. MALAYSIA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY CONSULTING SERVICES, 2018-2030 (USD MILLION)
  • TABLE 125. MALAYSIA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY MANUFACTURING SERVICES, 2018-2030 (USD MILLION)
  • TABLE 126. MALAYSIA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY FINISHED DOSAGE FORM MANUFACTURING, 2018-2030 (USD MILLION)
  • TABLE 127. MALAYSIA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY RESEARCH SERVICES, 2018-2030 (USD MILLION)
  • TABLE 128. MALAYSIA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY CLINICAL RESEARCH SERVICES, 2018-2030 (USD MILLION)
  • TABLE 129. MALAYSIA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 130. PHILIPPINES PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 131. PHILIPPINES PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY CONSULTING SERVICES, 2018-2030 (USD MILLION)
  • TABLE 132. PHILIPPINES PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY MANUFACTURING SERVICES, 2018-2030 (USD MILLION)
  • TABLE 133. PHILIPPINES PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY FINISHED DOSAGE FORM MANUFACTURING, 2018-2030 (USD MILLION)
  • TABLE 134. PHILIPPINES PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY RESEARCH SERVICES, 2018-2030 (USD MILLION)
  • TABLE 135. PHILIPPINES PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY CLINICAL RESEARCH SERVICES, 2018-2030 (USD MILLION)
  • TABLE 136. PHILIPPINES PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 137. SINGAPORE PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 138. SINGAPORE PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY CONSULTING SERVICES, 2018-2030 (USD MILLION)
  • TABLE 139. SINGAPORE PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY MANUFACTURING SERVICES, 2018-2030 (USD MILLION)
  • TABLE 140. SINGAPORE PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY FINISHED DOSAGE FORM MANUFACTURING, 2018-2030 (USD MILLION)
  • TABLE 141. SINGAPORE PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY RESEARCH SERVICES, 2018-2030 (USD MILLION)
  • TABLE 142. SINGAPORE PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY CLINICAL RESEARCH SERVICES, 2018-2030 (USD MILLION)
  • TABLE 143. SINGAPORE PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 144. SOUTH KOREA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 145. SOUTH KOREA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY CONSULTING SERVICES, 2018-2030 (USD MILLION)
  • TABLE 146. SOUTH KOREA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY MANUFACTURING SERVICES, 2018-2030 (USD MILLION)
  • TABLE 147. SOUTH KOREA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY FINISHED DOSAGE FORM MANUFACTURING, 2018-2030 (USD MILLION)
  • TABLE 148. SOUTH KOREA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY RESEARCH SERVICES, 2018-2030 (USD MILLION)
  • TABLE 149. SOUTH KOREA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY CLINICAL RESEARCH SERVICES, 2018-2030 (USD MILLION)
  • TABLE 150. SOUTH KOREA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 151. TAIWAN PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 152. TAIWAN PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY CONSULTING SERVICES, 2018-2030 (USD MILLION)
  • TABLE 153. TAIWAN PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY MANUFACTURING SERVICES, 2018-2030 (USD MILLION)
  • TABLE 154. TAIWAN PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY FINISHED DOSAGE FORM MANUFACTURING, 2018-2030 (USD MILLION)
  • TABLE 155. TAIWAN PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY RESEARCH SERVICES, 2018-2030 (USD MILLION)
  • TABLE 156. TAIWAN PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY CLINICAL RESEARCH SERVICES, 2018-2030 (USD MILLION)
  • TABLE 157. TAIWAN PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 158. THAILAND PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 159. THAILAND PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY CONSULTING SERVICES, 2018-2030 (USD MILLION)
  • TABLE 160. THAILAND PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY MANUFACTURING SERVICES, 2018-2030 (USD MILLION)
  • TABLE 161. THAILAND PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY FINISHED DOSAGE FORM MANUFACTURING, 2018-2030 (USD MILLION)
  • TABLE 162. THAILAND PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY RESEARCH SERVICES, 2018-2030 (USD MILLION)
  • TABLE 163. THAILAND PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY CLINICAL RESEARCH SERVICES, 2018-2030 (USD MILLION)
  • TABLE 164. THAILAND PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 165. VIETNAM PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 166. VIETNAM PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY CONSULTING SERVICES, 2018-2030 (USD MILLION)
  • TABLE 167. VIETNAM PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY MANUFACTURING SERVICES, 2018-2030 (USD MILLION)
  • TABLE 168. VIETNAM PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY FINISHED DOSAGE FORM MANUFACTURING, 2018-2030 (USD MILLION)
  • TABLE 169. VIETNAM PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY RESEARCH SERVICES, 2018-2030 (USD MILLION)
  • TABLE 170. VIETNAM PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY CLINICAL RESEARCH SERVICES, 2018-2030 (USD MILLION)
  • TABLE 171. VIETNAM PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 172. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 173. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY CONSULTING SERVICES, 2018-2030 (USD MILLION)
  • TABLE 174. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY MANUFACTURING SERVICES, 2018-2030 (USD MILLION)
  • TABLE 175. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY FINISHED DOSAGE FORM MANUFACTURING, 2018-2030 (USD MILLION)
  • TABLE 176. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY RESEARCH SERVICES, 2018-2030 (USD MILLION)
  • TABLE 177. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY CLINICAL RESEARCH SERVICES, 2018-2030 (USD MILLION)
  • TABLE 178. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 179. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 180. DENMARK PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 181. DENMARK PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY CONSULTING SERVICES, 2018-2030 (USD MILLION)
  • TABLE 182. DENMARK PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY MANUFACTURING SERVICES, 2018-2030 (USD MILLION)
  • TABLE 183. DENMARK PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY FINISHED DOSAGE FORM MANUFACTURING, 2018-2030 (USD MILLION)
  • TABLE 184. DENMARK PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY RESEARCH SERVICES, 2018-2030 (USD MILLION)
  • TABLE 185. DENMARK PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY CLINICAL RESEARCH SERVICES, 2018-2030 (USD MILLION)
  • TABLE 186. DENMARK PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 187. EGYPT PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 188. EGYPT PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY CONSULTING SERVICES, 2018-2030 (USD MILLION)
  • TABLE 189. EGYPT PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY MANUFACTURING SERVICES, 2018-2030 (USD MILLION)
  • TABLE 190. EGYPT PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY FINISHED DOSAGE FORM MANUFACTURING, 2018-2030 (USD MILLION)
  • TABLE 191. EGYPT PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY RESEARCH SERVICES, 2018-2030 (USD MILLION)
  • TABLE 192. EGYPT PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY CLINICAL RESEARCH SERVICES, 2018-2030 (USD MILLION)
  • TABLE 193. EGYPT PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 194. FINLAND PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 195. FINLAND PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY CONSULTING SERVICES, 2018-2030 (USD MILLION)
  • TABLE 196. FINLAND PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY MANUFACTURING SERVICES, 2018-2030 (USD MILLION)
  • TABLE 197. FINLAND PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY FINISHED DOSAGE FORM MANUFACTURING, 2018-2030 (USD MILLION)
  • TABLE 198. FINLAND PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY RESEARCH SERVICES, 2018-2030 (USD MILLION)
  • TABLE 199. FINLAND PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY CLINICAL RESEARCH SERVICES, 2018-2030 (USD MILLION)
  • TABLE 200. FINLAND PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 201. FRANCE PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 202. FRANCE PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY CONSULTING SERVICES, 2018-2030 (USD MILLION)
  • TABLE 203. FRANCE PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY MANUFACTURING SERVICES, 2018-2030 (USD MILLION)
  • TABLE 204. FRANCE PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY FINISHED DOSAGE FORM MANUFACTURING, 2018-2030 (USD MILLION)
  • TABLE 205. FRANCE PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY RESEARCH SERVICES, 2018-2030 (USD MILLION)
  • TABLE 206. FRANCE PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY CLINICAL RESEARCH SERVICES, 2018-2030 (USD MILLION)
  • TABLE 207. FRANCE PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 208. GERMANY PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 209. GERMANY PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY CONSULTING SERVICES, 2018-2030 (USD MILLION)
  • TABLE 210. GERMANY PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY MANUFACTURING SERVICES, 2018-2030 (USD MILLION)
  • TABLE 211. GERMANY PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY FINISHED DOSAGE FORM MANUFACTURING, 2018-2030 (USD MILLION)
  • TABLE 212. GERMANY PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY RESEARCH SERVICES, 2018-2030 (USD MILLION)
  • TABLE 213. GERMANY PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY CLINICAL RESEARCH SERVICES, 2018-2030 (USD MILLION)
  • TABLE 214. GERMANY PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 215. ISRAEL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 216. ISRAEL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY CONSULTING SERVICES, 2018-2030 (USD MILLION)
  • TABLE 217. ISRAEL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY MANUFACTURING SERVICES, 2018-2030 (USD MILLION)
  • TABLE 218. ISRAEL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY FINISHED DOSAGE FORM MANUFACTURING, 2018-2030 (USD MILLION)
  • TABLE 219. ISRAEL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY RESEARCH SERVICES, 2018-2030 (USD MILLION)
  • TABLE 220. ISRAEL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY CLINICAL RESEARCH SERVICES, 2018-2030 (USD MILLION)
  • TABLE 221. ISRAEL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 222. ITALY PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 223. ITALY PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY CONSULTING SERVICES, 2018-2030 (USD MILLION)
  • TABLE 224. ITALY PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY MANUFACTURING SERVICES, 2018-2030 (USD MILLION)
  • TABLE 225. ITALY PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY FINISHED DOSAGE FORM MANUFACTURING, 2018-2030 (USD MILLION)
  • TABLE 226. ITALY PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY RESEARCH SERVICES, 2018-2030 (USD MILLION)
  • TABLE 227. ITALY PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY CLINICAL RESEARCH SERVICES, 2018-2030 (USD MILLION)
  • TABLE 228. ITALY PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 229. NETHERLANDS PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 230. NETHERLANDS PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY CONSULTING SERVICES, 2018-2030 (USD MILLION)
  • TABLE 231. NETHERLANDS PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY MANUFACTURING SERVICES, 2018-2030 (USD MILLION)
  • TABLE 232. NETHERLANDS PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY FINISHED DOSAGE FORM MANUFACTURING, 2018-2030 (USD MILLION)
  • TABLE 233. NETHERLANDS PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY RESEARCH SERVICES, 2018-2030 (USD MILLION)
  • TABLE 234. NETHERLANDS PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY CLINICAL RESEARCH SERVICES, 2018-2030 (USD MILLION)
  • TABLE 235. NETHERLANDS PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY END-